Aqsens Health and Equity Health Insurance sign a Memorandum of Understanding to deepen their collaboration in Ghana

Aqsens Health (Finland) and Equity Health Insurance (Ghana) signed a Memorandum of Understanding to accelerate market entry for AQ Malaria and other future tests for developing economies.  The two companies are also working on a business plan to incorporate a local subsidiary for Aqsens in Ghana, which will focus on Ghanaian and West-African markets.


Aqsens Health’s CEO Timo Teimonen, COO Riikka Erkkilä and Aqsens’ founder and board member Professor Pekka Hänninen visited Ghana last week to meet with key stakeholders and sign the MOU with Equity Health Insurance CEO and President Elton Afari. 

Equity Health Insurance is a Ghanaian privately owned health insurance company, which offers health insurance protection with a novel model. Equity Health Insurance combines  insurance protection with diagnostics, pharmacy services and respective treatment through its growing Medcare Plus clinic chain in Ghana.

Through this partnership Aqsens Health and Equity Health Insurance aim to develop a larger portfolio of tests using E-TRF and biosensors. The two companies hope to create a positive socio-economic impact in Ghana by utilizing Aqsens’ Service model in the Ghanaian healthcare system. 

Aqsens Health and Equity Health Insurance share a vision of enabling better and more equal access to healthcare across Ghana by developing and providing affordable screening services for diseases that affect both individuals and the society as a whole. This MOU is a significant step forward in the growing partnership. 

For more information, contact:

CEO and Co-Founder 

Timo Teimonen

+358 40 5853105

timo.teimonen@aqsens.com

Previous
Previous

Tapping into the full potential of E-TRF and biosensors

Next
Next

Updates from Ghana – Starting the E-TRF measurement of 2,800 malaria saliva samples